Mak Ho-Yin, Dai Tinglong, Tang Christopher S
McDonough School of Business Georgetown University 37th and O Streets, NW Washington District of Columbia USA.
Carey Business School Johns Hopkins University 100 International Drive Baltimore Maryland USA.
Prod Oper Manag. 2022 Oct 7. doi: 10.1111/poms.13862.
Distributing scarce resources such as COVID-19 vaccines is often a highly time-sensitive and mission-critical operation. Our research was prompted by a significant obstacle that the United States and other nations encountered during the early months of the COVID-19 vaccination campaign: Most COVID-19 vaccines require two doses given 3 or 4 weeks apart. Given the severely limited supply and mounting pressure on many countries to reduce hospitalizations and mortality, how to effectively roll out two-dose vaccines was a critical policy decision. In this paper, we first model and analyze inventory dynamics of the rollout process under three rollout strategies: (1) holding back second doses, (2) releasing second doses, and (3) stretching the lead time between doses. Then we develop an SEIR (susceptible, exposed, infectious, recovered) model that incorporates COVID-19 asymptomatic and symptomatic infections to evaluate these strategies in terms of infections, hospitalizations, and mortality. Among our findings, we show releasing second doses reduces infections but creates uneven vaccination patterns. In addition, to ensure second doses are given on time without holding back inventory, strictly less than half of the supply can be allocated to first-dose appointments. Stretching the between-dose lead time flattens the infection curve and reduces both hospitalizations and mortality compared with the strategy of releasing second doses. We also consider an alternative single-dose vaccine with lower efficacy and show that the vaccine can be more effective than its two-dose counterparts in reducing infections and mortality. We conduct extensive sensitivity analyses related to age composition, risk-based prioritization, supply disruptions, and disease transmissibility. Our paper provides important implications for policymakers to develop effective vaccine rollout strategies in developed and developing countries alike. More broadly, our paper sheds light on how to develop effective operations strategies for distributing time-sensitive resources in times of crisis.
分配新冠疫苗等稀缺资源通常是一项时间高度敏感且任务关键的行动。我们的研究是由美国和其他国家在新冠疫苗接种运动最初几个月遇到的一个重大障碍引发的:大多数新冠疫苗需要分两剂接种,间隔3或4周。鉴于供应严重有限,且许多国家面临着降低住院率和死亡率的巨大压力,如何有效推广两剂疫苗是一项关键的政策决策。在本文中,我们首先对三种推广策略下的推广过程库存动态进行建模和分析:(1)扣留第二剂;(2)发放第二剂;(3)延长两剂之间的间隔时间。然后,我们开发了一个包含新冠无症状和有症状感染的SEIR(易感、暴露、感染、康复)模型,以从感染、住院和死亡率方面评估这些策略。在我们的研究结果中,我们表明发放第二剂可减少感染,但会造成接种模式不均衡。此外,为确保按时发放第二剂而不积压库存,分配给第一剂预约的供应量必须严格少于一半。与发放第二剂的策略相比,延长两剂之间的间隔时间可使感染曲线趋于平缓,并降低住院率和死亡率。我们还考虑了一种效力较低的替代单剂疫苗,并表明该疫苗在减少感染和死亡率方面可能比两剂疫苗更有效。我们针对年龄构成、基于风险的优先排序、供应中断和疾病传播性进行了广泛的敏感性分析。我们的论文为政策制定者在发达国家和发展中国家制定有效的疫苗推广策略提供了重要启示。更广泛地说,我们的论文阐明了在危机时期如何制定有效的运营策略来分配时间敏感资源。